ECARX director reports vested stock option holdings

ECARX Holdings Inc. director ZHANG XINGSHENG filed an initial ownership report showing vested share options granted under the company’s incentive plans.

Rhea-AI Filing Summary

ECARX Holdings Inc. director ZHANG XINGSHENG filed an initial ownership report showing vested share options granted under the company’s incentive plans. The options allow him to buy Class A ordinary shares at an exercise price of $0.5000 per share, with tranches covering 46,952, 123,362 and 101,266 underlying shares expiring between 2033 and 2035. All of these options were fully vested as of the date of this Form 3.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider ZHANG XINGSHENG

Role Director

Type	Security	Shares	Price	Value
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--
holding	Share options (right to buy)	--	--	--

Holdings After Transaction: Share options (right to buy) — 271,580 contracts (Direct)

Footnotes (1)

1. F1. Represents options granted to the reporting person pursuant to the issuer's share incentive plans, all of which have vested as of the date of this Form 3.

FAQ

What does ZHANG XINGSHENG’s Form 3 filing for ECARX (ECX) show?

The Form 3 shows ZHANG XINGSHENG’s initial holdings of vested share options in ECARX. These options were granted under company incentive plans and give him rights to acquire Class A ordinary shares at a fixed price over several future years.

How many ECARX (ECX) shares are covered by ZHANG XINGSHENG’s options?

The filing lists three vested option grants covering 46,952, 123,362 and 101,266 underlying Class A ordinary shares. Each grant represents a separate block of options with its own expiration date, forming part of his overall equity-based compensation package.

What is the exercise price of the ECARX (ECX) options held by ZHANG XINGSHENG?

All listed options have an exercise price of $0.5000 per Class A ordinary share. This means he can purchase shares at that fixed price, subject to exercising the options before they expire on the respective dates disclosed in the filing.

When do ZHANG XINGSHENG’s ECARX (ECX) share options expire?

The options reported in the Form 3 expire on December 31, 2033, December 31, 2034 and December 31, 2035. Each grant has its own expiration date, defining how long he has the right to exercise those particular options.

Are the ECARX (ECX) share options held by ZHANG XINGSHENG vested?

Yes. A footnote explains that the reported options were granted under ECARX’s share incentive plans and that all of them had vested as of the Form 3 date, meaning they are fully earned and currently exercisable subject to their future expiration dates.

Does ZHANG XINGSHENG’s ECARX (ECX) Form 3 show any recent share purchases or sales?

No buy or sell transactions are reported. The Form 3 is an initial statement of beneficial ownership listing vested option holdings, not new open-market trades. Transaction fields are classified as “holding” entries with unknown transaction codes and neutral net buy-sell direction.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/18/2026 - 06:14 PM Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

ZHANG XINGSHENG

(Last) (First) (Middle)

3502 BISHOP PL

(Street)

COQUITLAM V3E 0K2

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
03/18/2026

3. Issuer Name and Ticker or Trading Symbol
ECARX Holdings Inc. [ ECX ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Share options (right to buy)	12/31/2023	12/31/2033	Class A Ordinary Shares	46,952(1)	$0.5	D
Share options (right to buy)	12/31/2024	12/31/2034	Class A Ordinary Shares	123,362(1)	$0.5	D
Share options (right to buy)	12/31/2025	12/31/2035	Class A Ordinary Shares	101,266(1)	$0.5	D

Explanation of Responses:

1. Represents options granted to the reporting person pursuant to the issuer's share incentive plans, all of which have vested as of the date of this Form 3.

	/s/ Xingsheng Zhang	03/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)